Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Rheumatoid Arthritis

  Free Subscription


18.03.2019

4 Ann Rheum Dis
1 Arthritis Res Ther
2 Clin Exp Rheumatol
2 Clin Rheumatol
1 Curr Opin Rheumatol
1 Drugs
4 J Rheumatol
2 Rheumatol Int


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Rheum Dis

  1. FENT G, Mankia K, Erhayiem B, Hunt L, et al
    First cardiovascular MRI study in individuals at risk of rheumatoid arthritis detects abnormal aortic stiffness suggesting an anti-citrullinated peptide antibody-mediated role for accelerated atherosclerosis.
    Ann Rheum Dis. 2019 Mar 9. pii: annrheumdis-2018-214975.
    PubMed     Text format    

  2. PISETSKY DS
    How the gut inflames the joints.
    Ann Rheum Dis. 2018;77:634-635.
    PubMed     Text format    

  3. WINTHROP KL, Baddley JW
    Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question.
    Ann Rheum Dis. 2018;77:631-633.
    PubMed     Text format    

  4. MULLEMAN D, Balsa A
    Adalimumab concentration-based tapering strategy: as good as the recommended dosage.
    Ann Rheum Dis. 2018;77:473-475.
    PubMed     Text format    


    Arthritis Res Ther

  5. FERREIRA CC, Campi-Azevedo AC, Peruhype-Magalhaes V, Coelho-Dos-Reis JG, et al
    Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis.
    Arthritis Res Ther. 2019;21:75.
    PubMed     Text format     Abstract available


    Clin Exp Rheumatol

  6. BURMESTER G, Nusslein H, von Hinuber U, Detert J, et al
    Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional FalphasT study.
    Clin Exp Rheumatol. 2019 Mar 7. pii: 13055.
    PubMed     Text format     Abstract available

  7. BEN KILANI MS, Cornelis F, Olaso R, Chaudru V, et al
    Investigation of candidate gene copy number identifies FCGR3B as a potential biomarker for rheumatoid arthritis.
    Clin Exp Rheumatol. 2019 Mar 7. pii: 13412.
    PubMed     Text format     Abstract available


    Clin Rheumatol

  8. BAE SC, Lee YH
    Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis.
    Clin Rheumatol. 2019 Mar 13. pii: 10.1007/s10067-019-04499.
    PubMed     Text format     Abstract available

  9. URETEN K, Erbay H, Maras HH
    Detection of rheumatoid arthritis from hand radiographs using a convolutional neural network.
    Clin Rheumatol. 2019 Mar 8. pii: 10.1007/s10067-019-04487.
    PubMed     Text format     Abstract available


    Curr Opin Rheumatol

  10. DAY AL, Curtis JR
    Opioid use in rheumatoid arthritis: trends, efficacy, safety, and best practices.
    Curr Opin Rheumatol. 2019 Mar 5. doi: 10.1097/BOR.0000000000000602.
    PubMed     Text format     Abstract available


    Drugs

  11. ELMAMOUN M, Chandran V
    Role of Methotrexate in the Management of Psoriatic Arthritis.
    Drugs. 2018;78:611-619.
    PubMed     Text format     Abstract available


    J Rheumatol

  12. SEWERIN P, Schleich C, Brinks R, Muller-Lutz A, et al
    Synovial perfusion assessed by dynamic contrast-enhanced MRI is associated to treatment response, remission, and cartilage quality in rheumatoid arthritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180832. doi: 10.3899/jrheum.180832.
    PubMed     Text format     Abstract available

  13. GOSSEC L, Strand V, Proudfoot C, Chen CI, et al
    Effects of Sarilumab on Patient-Reported Impact of Rheumatoid Arthritis Using the Rheumatoid Arthritis Impact of Disease Scale.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180904. doi: 10.3899/jrheum.180904.
    PubMed     Text format     Abstract available

  14. MALOCHET-GUINAMAND S, Lambert C, Gossec L, Soubrier M, et al
    Evaluation of the implementation of guidelines on the treatment of osteoporosis in patients with rheumatoid arthritis.
    J Rheumatol. 2019 Mar 15. pii: jrheum.180889. doi: 10.3899/jrheum.180889.
    PubMed     Text format     Abstract available

  15. SLIM Z, de Moura CS, Bernatsky S, Rahme E, et al
    Capture of Rheumatoid Arthritis Cases within Quebec Health Administrative Database.
    J Rheumatol. 2019 Mar 15. pii: jrheum.181121. doi: 10.3899/jrheum.181121.
    PubMed     Text format     Abstract available


    Rheumatol Int

  16. LEE HN, Kim YK, Kim GT, Ahn E, et al
    Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as predictors of 12-week treatment response and drug persistence of anti-tumor necrosis factor-alpha agents in patients with rheumatoid arthritis: a retrospective chart review analysis.
    Rheumatol Int. 2019 Mar 14. pii: 10.1007/s00296-019-04276.
    PubMed     Text format     Abstract available

  17. UNAL O, Can ME, Ozcan A, Ozcan ME, et al
    Color Doppler imaging of ocular hemodynamic changes in patients with rheumatoid arthritis unrelated to disease activity.
    Rheumatol Int. 2019 Mar 12. pii: 10.1007/s00296-019-04275.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: